P47551 AF NFT

Uncharacterized lipoprotein MG309

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidq5so2yziobwuqdtjgy2kreo7chfbyhlxwa3tc34wxf7ixigqaay/metadata.json
IPFS of structure file: 
bafybeihxgix5qft2pd5yj4axw2tz7w6k63i4liqdvztqi4bwf6xaxtbzne/AF-P47551-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x9188600a0FCa2914254C94299b1bd9721Bc4D500
First NFT owner address (bech32): 
genesis1jxyxqzs0eg53gf2vjs5ekx7ewgduf4gquehckf
Current NFT ID #514514 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
514514
Accession (UniProt):
P47551
Name::
Uncharacterized lipoprotein MG309
Experimental Method:
Predicted structure
Sequence source:
MYCOPLASMA GENITALIUM (STRAIN ATCC 33530 / G-37 / NCTC 10195)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P47551 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P47551|Y309_MYCGE Uncharacterized lipoprotein MG309 OS=Mycoplasma genitalium (strain ATCC 33530 / G-37 / NCTC 10195) OX=243273 GN=MG309 PE=3 SV=2 MKRFLHRVKWPLLLSSIAVSLGIVAVACAQPNSRTIENLFRPSSAFTDKNDGSINATLYKALENREGLTQYLTMRLAPVLRNFYEENVDDDIKRNLRTFNTDTDNSFVNQEQNLRNQYRGDYLVRLQTDILDNTGGNQANWKLRDVNNKIVDDFINKLFTKNFVEYVDKSVGVLSTPLKGLIENQSNWNNIKIQAKFVDKNKRLRINNDAVYAAIQDKLLDQFVTNENPNLVSRVVFTNETPNDGFDNYFNPDLIKSPTPSYQFQVFNKYNQQDNSIKGANGFHILASNLQSYVNTNNKTIDIPNKFSSDSGGKLLLKASDMFDTFDPSFSAAFIQGYLALQKKSKGAEQTEYTKLEKDKSIIENFFVENNSAKAAMKSASSSSQTTTVHKTDLAKIFKENETTKSTDVFKGEYQKKFSNATSTSNSDSSNNSAIVDLKELKKDNNSQPDLILARGKDGIHLMGVDGGGYYLSESGRDVNKQKQFLLFRALQTKYGLIDTNTTYDFKLFDEVKKHFDKNRVLFLFNALFKLVDSKESNFLSFPQFKKFSDSIITVKNELKDLVESQYQQIVFNEVATAENKVALKLAERNQPFIDNERNKQIWMNGLAAVLPYEQDSKTGHYNELGIYYKDIIDKVSSNTSNSNSNSNSSSSDPFSKKIIDKLKENKKKVEAAVKKHVDELKVSVIPSPQYSQIILVDTKLSSDPRNTSLALNLALNAVLSSDELQNTIRRDYFVNDDQFKQAIDLDKLTFKNWNSLNNENWNIFKYTYLFDLFQKQANPSIFGNGVNESSTDNKPKINGVLDSLYNSLNLEERLDSNDLINYYSYLYTVQWLLKDNLKNLKQNLQAKLSRTTNSFLVWSLASDKDRNNTASQAMSVSSSKSVLVKMANNVASQTNQDFTKQEQQNPNYVFGSSAYNWTNNKTPTVNSAANDISSLYYTKNNGSSSTSLTLMQKSAQQTNNQQRRFGFHGIVTNTSSNNLPDAVRNRLFTSFVSQSEKSSSNGGQAQLQSTQSSGSNETIYKGALFSFGSLTKLIETIDNIPTQAEFDALYNHLTSNLNINVTGVDRSKSLQEQKTNLKNFANSNFNNTQTVQLKQAQSKTNNSNFNDVFSRFEGYIGTNKTSNYSSYNFLQDNQIYHAVYAKQINLEDVSMLGSDSLNSTDSNNSKRLDLSLEEFLSTVALEALNPNNQTQAINALIANAKNGLVRVGDNRLFSAISSQWVRKF